Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SLC-3010 |
Trade Name | |
Synonyms | SLC 3010|SLC3010 |
Drug Descriptions |
SLC-3010 is a conjugate of IL-2 linked to an anti-IL2 antibody, which potentially induces increased antitumor immune response and inhibits tumor growth (Cancer Res (2021) 81 (13_Supplement): 689). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + SLC-3010 | Gemcitabine SLC-3010 | 0 | 1 |
SLC-3010 | SLC-3010 | 0 | 1 |